Written by Klarity Editorial Team
Published: Aug 18, 2026

Last updated: August 18, 2026
Regular insulin is short-acting human insulin. Brand names you will see most often are Humulin R (Lilly) and Novolin R (Novo Nordisk). People also search “Humulin R insulin,” “Novolin R insulin,” “regular human insulin,” and “Huminsulin R.” Those names point to clear U-100 Regular insulin, not cloudy NPH, not analog meal-time pens such as Humalog or NovoLog, and not concentrated Humulin R U-500 unless a clinician prescribed that strength on purpose. Regular insulin is a meal-time (bolus) insulin. It is not a once-daily analog basal such as Lantus or Tresiba.
This guide covers how Regular insulin is usually injected, why it must stay clear, how U-100 differs from U-500, how mixing with NPH works when a clinician orders it, and when a video visit is enough versus when you need labs or the ER. It is educational. It is not a diagnosis or a promise that any specific insulin will be prescribed. Do not change brands, strengths, or units on your own.
Want a licensed clinician to review meal-time insulin or an A1C? Klarity Health has 2,000+ licensed providers. Many visits happen online. See online prescription options or browse conditions.
Type 1 diabetes means the pancreas makes little or no insulin. Type 2 diabetes means the body resists insulin and often does not make enough of it. Glucose stays in the blood. Over years that raises the chance of heart disease, stroke, kidney disease, nerve damage, and eye disease. NIDDK notes some people with type 2 diabetes can control glucose with food, activity, sleep, and weight change. Many still need pills or insulin. Over time you may need more than one medicine (NIDDK insulin and medicines).
Human insulin replaces what the pancreas would have made. MedlinePlus says it moves sugar from the blood into tissues and slows the liver from making more sugar. The types differ in how fast they start and how long they last. Regular sits on the meal-time side: slower than analog rapid-acting insulin (lispro, aspart, glulisine), faster and shorter than NPH or analog basal products such as insulin glargine or insulin degludec.
Typical home targets the CDC lists for many adults:
Blood sugar under 70 mg/dL is low. If you are sick and a reading is 240 mg/dL or higher, check ketones. High ketones can signal diabetic ketoacidosis, which is an emergency. Hospital DKA treatment often uses IV Regular insulin. That is not a home self-mix.
Related Klarity guides: NPH (Humulin N, Novolin N), Lantus (insulin glargine), Tresiba (insulin degludec), Levemir (insulin detemir), Toujeo (insulin glargine U-300), type 2 diabetes medication.
DailyMed describes Humulin R U-100 as recombinant human insulin, structurally identical to human insulin, 100 units/mL, clear and colorless. Insulin lowers blood glucose by stimulating uptake in muscle and fat and by inhibiting glucose production in the liver. Duration depends on dose, injection site, blood supply, temperature, and activity.
With a subcutaneous dose in the 0.05 to 0.4 units/kg range, DailyMed lists an onset of about 30 minutes, a peak around 3 hours, and an end around 8 hours. Ranges are wide. That is why the same unit count can feel different on a walk versus a rest day, or in the abdomen versus the thigh.
Cleveland Clinic’s chart groups Regular (Novolin R, Humulin R) as onset 30 to 60 minutes, peak 2 to 4 hours, duration 5 to 8 hours. Rapid-acting analogs start in about 5 to 15 minutes and last about 3 to 5 hours. That gap is why Regular usually needs a longer lead time before the first bite, and why a late lunch can still collide with Regular’s peak.
Mayo Clinic’s type 1 overview also lists Humulin R and Novolin R as short-acting examples, with peak around 90 to 120 minutes and duration about 4 to 6 hours in that article’s table. Charts do not all use the same study. Follow the timing your clinician wrote for your brand and meal pattern, not a screenshot from a different product.
Most people who search Humulin R or Novolin R mean U-100: 100 units in each milliliter. DailyMed’s U-100 vial carton is labeled 10 mL, 100 units per mL. Use a U-100 syringe. A mismatch in syringe markings can underdose or overdose.
Humulin R U-500 is five times as concentrated (500 units/mL). DailyMed indicates it for adults and children who need more than 200 units of insulin per day. Limitations: safety with other insulins and with continuous subcutaneous infusion (pumps) has not been determined. Mayo Clinic: measure U-500 carefully; if you use the vial, use a U-500 insulin syringe; eat a meal within 30 minutes of injecting U-500. Never treat U-500 as “the same shot, smaller volume” without training. A video visit can review whether concentrated insulin is even on the table. It cannot replace the first in-person teach for a new U-500 pen or syringe.
Home Regular is almost always subcutaneous. MedlinePlus lists stomach, upper arm, upper leg, or buttocks. Skip muscle, scars, and moles. Rotate at least 1/2 inch from the last poke in the same region before you switch regions. Mayo Clinic: skip skin that is tender, bruised, scaly, hard, thick, or scarred.
Cleveland Clinic: take Regular about 30 minutes before eating. Analog rapid-acting insulin can sit closer to the meal (up to about 15 minutes before). If you inject Regular and then delay the meal, the peak still arrives. Lows show up in that window.
Mixing with NPH is common when a clinician writes it that way. MedlinePlus: always draw the same type first; never mix more than one type unless you were told to. Cleveland Clinic: Regular may be mixed with NPH; do not mix Lilly Regular with Novo Nordisk NPH. DailyMed’s Humulin R vial instructions include a section on mixing with longer-acting human insulins and say to stay consistent about mixing ahead versus mixing just before the shot. Analog basal pens (Lantus, Tresiba, Toujeo, Levemir) are a different rule set. Do not assume you can mix Regular into those.
IV Regular is a clinic or hospital tool. MedlinePlus names Myxredlin, Humulin R U-100, and Novolin R as solutions that may be given into a vein by a clinician. DailyMed: potassium must be watched closely with IV insulin because insulin can drop potassium. That is not a kitchen-table infusion.
Never share needles, syringes, cartridges, or pens. DailyMed: never share needles and syringes. U-500 adds: never share a KwikPen or U-500 syringe.
DailyMed indicates Humulin R U-100 for adults and children with type 1 or type 2 diabetes, as an adjunct to diet and exercise. Mayo Clinic: pediatric studies have not shown problems that would limit Humulin R or Myxredlin in children. Humulin R U-500 has not established pediatric safety and efficacy in Mayo’s write-up. Older adults may need more caution because lows and kidney, liver, or heart disease are more common.
Do not use Regular during an active low. DailyMed contraindicates Humulin R U-100 during hypoglycemia and in people hypersensitive to the product or its excipients. Mayo Clinic lists hypoglycemia as a reason not to take a dose, and lists heart failure and low potassium as conditions insulin can worsen.
Kidney or liver disease can change how long insulin lasts. Illness, infection, stress, and steroids can raise the dose you need. Pregnancy needs closer glucose work; DailyMed notes insulin needs often fall in the first trimester, rise later, and drop after delivery. Breastfeeding: Mayo Clinic cites minimal infant risk; dose and food may still need a tweak.
Hypoglycemia is the most common insulin problem. DailyMed lists sudden sweating, dizziness, tremor, hunger, blurred vision, headache, and, when severe, disorientation, seizures, unconsciousness, or death. Mild lows often respond to glucose tablets or another fast sugar your clinician named. If you cannot swallow or you pass out, that is glucagon or 911, not another home unit of Regular.
DailyMed also flags hyperglycemia and DKA if you take less than you need: thirst, extra urine, loss of appetite, fatigue, abdominal pain, nausea, fruity breath, heavy breathing. Insulin can drop potassium. Generalized allergy (whole-body rash, wheeze, low blood pressure) is uncommon and urgent.
Injection-site redness, thickening, or small dents (lipodystrophy) show up when the same spot is used too often. Weight gain can occur as glucose moves into cells. MedlinePlus also lists constipation as a possible effect.
Beta-blockers and other medicines can hide or change low-sugar warning signs. Alcohol can drop glucose. Tell the clinician about niacin, salicylates, steroids, and every diabetes pill. If you also take a TZD such as pioglitazone, watch for swelling or sudden weight gain; concentrated U-500 labeling specifically calls out fluid retention and heart failure with PPAR-gamma agonists. See Klarity’s TZD / pioglitazone guide.
A licensed clinician on video can review home logs, A1C, meal timing, Regular versus analog bolus, NPH mix technique, and whether U-100 versus U-500 is even relevant. They can refill a stable regimen when your state and the product allow it, and they can send you for labs.
They cannot start IV Regular, treat DKA at your kitchen table, or safely convert you from U-100 to U-500 without a clear total daily dose, teaching, and the right syringe or pen. New severe lows, vision changes you cannot explain, chest pain, or ketones with vomiting belong in urgent or emergency care.
Medicare patients can receive many non-behavioral telehealth visits from home through December 31, 2027, with no geographic restriction in current HHS policy. Plan coverage for the insulin itself still varies. Confirm your pharmacy benefit before you assume a brand is preferred.
Need help sorting Regular insulin questions with a licensed clinician? See online prescription options or browse conditions. Coverage may vary by plan. Verify benefits before you book.
Some Regular insulin products are sold over the counter in U.S. pharmacies as human insulin, while analog pens stay prescription-only. That does not mean self-starting insulin is safe. Dose, mix order, and U-100 versus U-500 still need a clinician. Insurance may cover vials, pens, syringes, and CGM supplies on different tiers. Prior authorization is common for analog alternatives. Coverage varies by plan. Patients should verify benefits before they change pharmacies or brands.
This article is not a coupon page and not a promise that Klarity or any plan will pay for Humulin R or Novolin R.
Both are Regular (short-acting) human insulin U-100 products. Brands and preservatives differ. Cleveland Clinic advises against mixing one maker’s Regular with another maker’s NPH. Do not switch brands without a plan for extra glucose checks.
DailyMed’s Humulin R U-100 subcutaneous profile is about 8 hours on average (range 3 to 14), with a peak near 3 hours. Cleveland Clinic lists 5 to 8 hours. Your meal, dose, and injection site change the curve.
Often yes, if your clinician wrote that mix and you draw in a consistent order. Do not mix Regular into analog basal insulin or into a pump cartridge unless a specialist program said to. U-500 Regular is not cleared for mixing with other insulins on the DailyMed U-500 label.
Humalog (insulin lispro) is rapid-acting. Regular is short-acting human insulin. Rapid-acting analogs usually start sooner and finish sooner, so they sit closer to the meal. Regular needs more lead time and can still be working several hours later.
A licensed clinician may prescribe or continue Regular insulin when it is medically appropriate and allowed in your state. They still need your history, glucose data, and a plan for lows. U-500 starts and DKA care stay in higher-acuity settings.
This page is for education. It is not medical advice, a diagnosis, or a guarantee of insurance coverage. Insulin products, doses, and mixing rules vary. Confirm your plan’s benefits and talk with a licensed clinician before you change insulin. Klarity Health has 2,000+ licensed providers. Coverage may vary by plan.
Find the right provider for your needs — select your state to find expert care near you.